Edgewell Personal Care (EPC) Research & Development (2009 - 2026)

Edgewell Personal Care (EPC) has 18 years of Research & Development data on file, last reported at $14.9 million in Q1 2026.

• On a quarterly basis, Research & Development rose 11.19% year-over-year to $14.9 million in Q1 2026; TTM through Mar 2026 was $58.5 million, a 1.39% increase from a year earlier, with the FY2025 full-year figure at $57.6 million, down 1.37% from the prior year.
• Research & Development for Q1 2026 stood at $14.9 million, up from $13.8 million in the prior quarter.
• Over the last five years, Research & Development for EPC reached as high as $16.3 million in Q3 2024 and fell as low as $13.3 million in Q4 2023.
• Historically, Research & Development has averaged $14.4 million across 5 years, with a median of $14.2 million in 2024.
• Across the five-year window, Research & Development slipped 6.85% in 2022 and rose 11.19% in 2026, its largest moves.
• Year by year, Research & Development stood at $13.4 million in 2022, then dropped by 0.75% to $13.3 million in 2023, then grew by 0.75% to $13.4 million in 2024, then gained by 2.99% to $13.8 million in 2025, then climbed by 7.97% to $14.9 million in 2026.
• Per Business Quant data, the three most recent Research & Development figures were $14.9 million in Q1 2026, $13.8 million in Q4 2025, and $15.8 million in Q3 2025.